Cleveland-Cliffs Stock Trading and Earnings Outlook
Analysis based on 6 articles · First reported Oct 09, 2024 · Last updated Sep 11, 2026
The event is a routine flow of single-stock trading updates and analyst estimate revisions for Cleveland Clinic, with no broad market-moving catalyst, so its impact is confined largely to CLF shares and sentiment toward the steel and basic materials sector. The upcoming earnings report and the direction of consensus estimates are the main near-term drivers for the stock, while the wider indexes are referenced only as performance benchmarks.
Cleveland Clinic (CLF) shares traded in a narrow range across several sessions in late August and September 2026, closing at $11.52 on August 25, $12.28 on September 3, $12.09 on September 9, and $12.06 on September 11. The stock moved +1.95% on August 25, -1.13% on September 3, -1.63% on September 9, and +1.94% on September 11, in each case against mixed performance in the broader indexes. Over the past month the shares fell roughly 0.97% to 7.76%, lagging the Basic Materials sector and the S&P 500 in most of the reported periods. Investor focus is on the company's upcoming earnings release, with consensus estimates calling for quarterly EPS of $0.24 to $0.25, representing year-over-year growth of about 153% to 156%, and quarterly revenue of $5.6 billion, up 18.28% from the year-ago quarter. For the full fiscal year, Zacks Consensus Estimates project a loss of $0.12 per share and revenue of $21.09 billion, year-over-year changes of +95.16% and +13.34% respectively. Analyst estimate revisions have been mixed, with the consensus EPS estimate moving 28.13% higher over 30 days in late August but 2.68% lower by early September. Cleveland Clinic carries a Zacks Rank of #3 (Hold), and the Steel - Producers industry has fluctuated between a Zacks Industry Rank of 98 and 160.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard